A patented, miniaturized fluidic pump system has been successfully developed and is now owned by our spinoff company. This innovation enables precise, automated fluid manipulation within organ-on-chip platforms, enhancing analytical accuracy and operational efficiency. The technology is ready for integration into advanced life sciences applications, opening new opportunities for automated biomedical research, drug screening, and next-generation lab automation.
Addressing target audiences and expressing needs
- Other blended financing
We are looking for investors and industry partners to help us bring our patented miniaturized fluidic pump system to market, expand its applications, and drive innovation in organ-on-chip technologies.
- Public or private funding institutions
- Academia/ Universities
- Private Investors
R&D, Technology and Innovation aspects
Our technology is currently at TRL 3. We are actively validating the system through experimental testing and are collecting data to support a forthcoming scientific publication. The next steps involve further development aimed at integrating the technology into a more robust, industrial-ready version suitable for commercial applications.
